1-(4-Amino-3-chlorophenyl)cyclopropanecarboxylic acid, 97.0%, 5g

PROPARGYL-PEG4-ACID, 95.0%, 250mg

cis-Ethyl 2-hydroxycyclopentanecarboxylate, 95.0%, 1g

(S)-(+)-1-Phenylethane-1,2-diol, 95.0%, 25g

2-Maleimidoethylamine hydrochloride, 97.0%, 5g

[(4-methoxyphenyl)thio]acetic acid, 95.0%, 2.5g

3,4-Difluoro-4'-(trans-4-pentylcyclohexyl)biphenyl>98.0%(GC)25g

4-Fluorophenethylisocyanide, 1g

2-(2,2,2-Trifluoroethoxy)acetic acid, 98%, 250mg

(S)-2-(2-CHLOROPHENYL)-2-((2-(THIOPHEN-2-YL)ETHYL)AMINO)ACETIC ACID, 95%, 1g

2-(1,4-dioxan-2-yl)ethanol, 95.0%, 1g

Triclorometano/cloroformo, mínimo 99 %, para síntesis, 2,5 l, envase de vidrio

3-Pyridinecarboxamide, N-[4-[(2-amino-3-chloro-4-pyridinyl)oxy]-3-fluorophenyl]-5-(4-fluorophenyl)-1,4-dihydro-4-oxo-, 99%, 250mg